Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU summary of clients entering treatment, 2007 or most recent year available [see all tables in this series...]

Part (iii) All outpatient clients, age at first use distribution by primary drug (%)

Substance	<15	15–19	20–24	25–29	30–34	35–39	40–44	45+	Mean age	Age known	Age not known
Opiates	6.9	43.2	29.0	11.8	5.2	2.4	1.0	0.5	21.5	71056	20306
Cocaine	7.3	41.9	26.2	12.6	6.4	3.2	1.6	0.8	22.0	33346	8436
Stimulants	12.7	57.5	18.1	6.1	2.8	1.3	0.3	1.1	19.8	5720	879
Hypnotics and sedatives	9.7	25.3	18.6	14.1	11.7	7.8	5.5	7.3	26.6	2012	641
Hallucinogens	19.1	51.6	20.2	3.7	3.2	2.1	0.0	0.0	19.0	188	72
Volatile substances	45.2	40.8	7.2	2.0	2.0	2.0	0.4	0.4	17.2	250	59
Cannabis	36.7	50.9	8.8	2.2	0.8	0.3	0.1	0.0	16.9	34430	7611
Other substances	21.0	40.2	18.8	8.1	5.0	2.3	1.6	3.0	21.0	960	446
Total	14.4	45.0	23.0	9.5	4.5	2.1	1.0	0.6	20.6	147962	38450

Notes:

 : indicates data not available 

 Countries reporting data: BE, BG, CZ, DK, DE, IE, EL, ES, FR, IT, CY, LU, HU, MT, NL, AT, RO, SI, SK, FI, SE, HR 

 Last data available from Spain and Malta refer to 2006.Last data available from Belgium refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7. 

 See also Table TDI-107 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2008 — Table TDI — outpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)